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Disease clusters continue to concern the pub-
lic, and public sentiment that environmental
causes are responsible and must be investi-
gated is widely prevalent. More than a decade
ago, the Centers for Disease Control and
Prevention (CDC) recognized the need to
develop operating procedures for response to
public concern about disease clusters. The
National Conference on Clustering of Health
Events was held 15–16 February 1989 in
Atlanta, Georgia; the proceedings were pub-
lished (Rothenberg et al. 1990a); and the CDC
released the “Guidelines for Investigating
Clusters of Health Events” (CDC 1990) in
which a four-stage process was presented: a)a n
initial response to gather source information,
b) an assessment of the occurrence of the health
event, c) a feasibility study, and d) an epidemio-
logic investigation. During the last 15 years,
these guidelines have provided a framework
that most state health departments have
adopted, modifying it for their speciﬁc situa-
tions and available resources. The states have
the primary responsibility for response to can-
cer cluster concerns within their domain. The
CDC guidelines emphasize the need for health
agencies to develop an approach that maintains
community relations while responding to clus-
ters efficiently; the approaches vary among
states as well as according to the nature of the
cluster and the availability of case and compari-
son data. The orientation of each state-based
inquiry response and investigation plan is
shaped by state philosophy and experience with
previous clusters. 
The purpose of this article is not to revise
the CDC guidelines; they retain their useful-
ness and validity. However, in the past
15 years, numerous cluster studies [Agency
for Toxic Substances and Disease Registry
(ATSDR) 2006; Cochise County Health
Department (CCHD) 2005; Heath 2005;
Massachusetts Department of Public Health
(MDPH) 2005; National Cancer Institute
(NCI) 2005; New Jersey Department of
Health and Senior Services (NJDHSS) 2004;
Rubin et al. 2007] as well as scientific and
technologic developments have affected clus-
ter science and response. Thus, we offer an
addendum for use with the original docu-
ment. Included in this list of significant
developments are improvements in cancer
registries, a federal initiative in environmental
public health tracking (EPHT), reﬁnement of
biomarker technology, new cluster identiﬁca-
tion and geographic information systems
(GIS) software, and the emergence of the
Internet. These developments have shaped the
approach of the CDC National Center for
Environmental Health (NCEH) for public
health response to cancer clusters. 
Role of the CDC/NCEH in
Cancer Cluster Response
Over the past several decades, industrialization
and urban growth have increased human
exposure to numerous toxic substances, and as
a result, concern has been raised about their
relationship to the etiology of chronic disease.
The association between environmental fac-
tors and disease was validated in recent studies
demonstrating that environmental factors
such as tobacco smoke, toxic chemicals,
dietary habits, and viral infections signiﬁcantly
increase the risk for several types of cancer
(Lichtenstein et al. 2000; Thomas and
Karagas 1996). A call for increased attention
directed toward investigation of environmen-
tal exposure as a cause of chronic disease has
been widely voiced in the media, the political
establishment, and scientiﬁc forums. 
NCEH defines a cancer cluster as a
greater-than-expected number of cancer cases
that occurs within a group of people in a geo-
graphic area over a deﬁned period of time. In
2000, representatives from the CDC Division
of Cancer Prevention and Control (DCPC),
National Institute for Occupational Safety
and Health (NIOSH), ATSDR, and NCEH
met and recognized the importance of a cen-
trally coordinated cancer cluster response to
inquiries within the CDC. They assigned this
responsibility to NCEH. The rationale for
this decision was the strong public perception
that environmental exposures are directly
responsible for cancer. NCEH now provides
a centralized coordinated response system for
cancer cluster inquiries received by the CDC.
Since the inception of this new responsibility,
NCEH has initiated several cluster-related
activities (Table 1). 
Cancer Cluster Public Inquiry Triage
System. In 2002, NCEH initiated a central-
ized inquiry system within the CDC, the
Cancer Cluster Public Inquiry Triage System
(CCPITS; CDC 2004) for responding to can-
cer cluster inquiries from various audiences
such as individual citizens, state health depart-
ments, and other federal agencies (Figure 1).
The goals of the system are to a) provide
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The Centers for Disease Control and Prevention (CDC) continues to be aware of the need for
response to public concern as well as to state and local agency concern about cancer clusters. In
1990 the CDC published the “Guidelines for Investigating Clusters of Health Events,” in which a
four-stage process was presented. This document has provided a framework that most state health
departments have adopted, with modifications pertaining to their specific situations, available
resources, and philosophy concerning disease clusters. The purpose of this present article is not to
revise the CDC guidelines; they retain their original usefulness and validity. However, in the past
15 years, multiple cluster studies as well as scientiﬁc and technologic developments have affected
cluster science and response (improvements in cancer registries, a federal initiative in environmen-
tal public health tracking, refinement of biomarker technology, cluster identification using geo-
graphic information systems software, and the emergence of the Internet). Thus, we offer an
addendum for use with the original document. Currently, to address both the needs of state health
departments as well as public concern, the CDC now a) provides a centralized, coordinated
response system for cancer cluster inquiries, b) supports an electronic cancer cluster listserver,
c) maintains an informative web page, and d) provides support to states, ranging from laboratory
analysis to epidemiologic assistance and expertise. Response to cancer clusters is appropriate pub-
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a timely manner, b) decrease the chances of an
inquirer having to contact multiple agencies,
and c) increase communication about cancer
clusters among the participating agencies. The
response from NCEH to individuals includes
basic information on cancer clusters, response
to the speciﬁc cancer cluster concern, referral
to the appropriate state health department and
state cancer registry contacts, and links to
additional information. NCEH also notifies
the state contacts of the inquiry and response.
The NCEH cancer cluster website (http://
www.cdc.gov/nceh/clusters; CDC 2004) was
developed and designed to support the inquiry
system and to facilitate information sharing
among federal, state, and local agencies; it pro-
vides the cornerstone for the cancer cluster
inquiry system. If the inquiry concerns a haz-
ardous waste site, work site, or basic cancer
issue, NCEH triages the inquiry to ATSDR,
CDC/NIOSH, or DCPC, respectively. NCEH
tracks inquiry information via an ACCESS
database (Microsoft Corp., Redmond, WA)
and communication among CDC programs,
federal, state, and local agencies is improved as a
result of this single point of contact. Since the
inception of the system through July 2005, the
cancers of concern most frequently cited by
inquirers were breast cancer, leukemia, brain
cancer, lung cancer, and colorectal cancer.
NCEH uses this information proactively to
develop additional tools to better serve the
needs of inquirers. 
When contacted about a potential cancer
cluster, NCEH defers to state health depart-
ments to provide the first level of response.
States examine their cancer registry data,
enabling comparison between incidence rates
at various geographic levels. State agencies are
in the best position to do this because they
maintain data on population demographics,
local health and environmental issues, and
previous investigations. NCEH becomes
involved when state health departments
request assistance. Several have requested
assistance from NCEH pertaining to cancer
clusters. NCEH response has ranged from
consultation with appropriate staff to active
participation in an epidemiologic or biosam-
pling investigation. In some cases, NCEH has
provided assistance by conducting analysis of
biological samples and storing them for future
study, as it did in the childhood leukemia
clusters in Churchill County, Nevada (CDC
2003a; Rubin et al. 2007) and Sierra Vista,
Arizona (CCHD 2005).
Media survey of cancer cluster reports.
Because the media plays a large role in shap-
ing public perception of cancer as well as
community concerns about cancer, NCEH
conducted a descriptive study of cancer clus-
ter reports in the popular media and charac-
terized the media reports retrieved. A
systematic search of newspaper articles on
cancer clusters was performed using DIA-
LOG (http://www.dialog.com/sources/
subject) and NEXIS (https://www.lexis.com/
research) databases. Media reports were cate-
gorized according to the specific incident
reported and characterized across several vari-
ables, including date, state, number of cita-
tions, and perceived environmental exposure
(Figure 2). The search produced a media
record database containing 1,440 records of
approximately 175 suspected cancer cluster
Kingsley et al.
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Table 1. Recent CDC-sponsored cancer cluster activities in the United States.
Year CDC cluster activities
2002 CCPITS
2002–2003 Survey of state protocols in cancer clusters (56 states/territories)
2002 State site visits (AZ, OH, NJ, MA)
2003 State and Federal Technical Capacity Building Workshop: Response to Cancer Clusters with 
Suspected Environmental Etiology (CA, FL, GA, MA, MD, MN, NY, SC, TX, WA; CDC 2003b)
2003 Electronic listserver (185 participants; CDC 2003c)
2002–2003 Survey of media reports on cancer clusters
2001–2003 Assistance to Nevada State Department of Health; Cross Sectional Exposure Assessment of Case
Children with Leukemia and a Reference Population in Churchill County, Nevada (CDC 2003a; 
Rubin et al. 2007)
2003–2005 Assistance to the CCHD and the Arizona Department of Health 
Services; Biosampling of Children with Leukemia plus a Comparison Population in Sierra Vista, 
Arizona (CCHD 2005)
Figure 1. NCEH Cancer Cluster Public Inquiry Triage System. Abbreviations: APRHB, Air Pollution and
Respiratory Health Branch; HSB, Health Studies Branch; RSB, Radiation Studies Branch; SHD, state health
department; U.S. EPA, U.S. Environmental Protection Agency.
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These data reflect the environmental com-
plexities associated with cancer cluster epi-
demiology as well as the breadth of popular
concern and awareness regarding issues of
exposure types, pollution sites, and specific
environmental chemicals. 
In attempting to report on issues of
importance to the public, such as the relation-
ship of apparent disease clusters to environ-
mental exposures, the media may occasionally
and perhaps unwittingly misrepresent scien-
tific issues and information (Blake 1995;
Nelkin 1996). The attempt of the media to
focus on human interest, conﬂicting informa-
tion, blame, and political symbolism may not
always be conducive to the presentation of
correct and unbiased information (Greenberg
and Wartenberg 1990). In addition the rela-
tionship between the environment and dis-
ease, and the science underlying cluster
investigation (e.g., definition of geographic
boundaries, calculation of expected rates of
disease, population demographics, etiology of
cancer, statistical issues) are complex topics
and can be difﬁcult for persons without scien-
tific education and training to comprehend
(Turney 1996). Thus, the media, whether
electronic, print, or other format, has both a
critical role and a significant opportunity in
the presentation of information surrounding
cluster investigations. 
State-specific activities. In 2001, NCEH
conducted a survey to assess state protocols for
responding to cancer cluster inquiries and
state criteria for conducting investigations.
This survey was part of an effort to deﬁne and
describe existing state-based activities concern-
ing suspected cancer clusters, identify gaps in
current investigation methods, and examine
opportunities for increasing the efﬁciency and
utility of state and federal efforts. The survey
instrument, developed by NCEH, was distrib-
uted to 56 states and territories (50 states plus
the District of Columbia, Guam, American
Samoa, Puerto Rico, the Federated States of
Micronesia, and the U.S. Virgin Islands).
Although the results of the survey indicated
considerable variation among protocols, as
well as their perspectives and experiences in
cancer cluster investigations, every state or ter-
ritory that completed the survey (89% partici-
pation rate) provided education concerning
cancer and/or cancer clusters to all inquirers as
part of their inquiry response. Criteria com-
monly used to determine whether to proceed
toward a more intense level of investigation of
a cluster included
• identiﬁcation of a single cancer type; 
• biological plausibility and adequate latency;
for the reported cancer;
• political pressure;
• identification of a common cancer in an
unusual age group;
• identiﬁcation of a rare cancer;
• identiﬁcation of exposure to a carcinogenic
substance; 
• elevated ratio of observed/expected con-
ﬁrmed cancer cases. 
To understand further the experiences of
state health departments during recent cancer
cluster investigations, NCEH conducted site
visits to four states (New Jersey, Arizona,
Massachusetts, Ohio) in which there were in-
depth investigations of leukemia in circum-
scribed areas, documented protocols for
handling cluster inquiries, and considerable
experience and expertise in the investigation
of disease clusters. 
NCEH also sponsored two workshops
during which representatives from 10 states
(Massachusetts, Florida, California, South
Carolina, Montana, New York, Georgia,
Minnesota, Texas, and Washington) met and
discussed cancer cluster activity. From these
workshops and site visits, several conclusions
were drawn. All states and territories placed a
high importance on educational components
and provided education to all callers. In addi-
tion most had standardized forms to facilitate
information gathering, took a systematic
approach, triaged incoming inquiries, were
interested in improved science and method-
ology, followed the framework suggested by
the 1990 CDC guidelines (CDC 1990), and
had cancer cluster websites. However,
response varied greatly depending upon state
experience and political considerations. All
states and territories were well aware of the
inherent complexities in cancer cluster inves-
tigations, including data quality, migration,
latency, small numbers, and political issues.
Most protocols were continuing to evolve. 
The states and territories listed several
needs during the workshops:
• validation from a federal agency;
• additional funding and personnel;
• training (e.g., CDC-sponsored workshops
on methods and media relations);
• CDC-facilitated information/data sharing; 
• assistance with complex investigations.
Details of the workshop proceedings may be
found at http://www.cdc.gov/nceh/clusters/
cluster_response.htm (CDC 2003b). 
In 2003 in response to a recommendation
voiced at the workshop, NCEH established an
electronic listserver (CDC 2003c) to facilitate
dialogue among the states and federal agency
staff and to provide a mechanism to share and
discuss data and scientiﬁc methods. 
Beginning in 2001, the CDC became
involved in two childhood leukemia cluster
investigations at the request of state and local
health departments. As part of these two
cross-sectional exposure assessments in
Churchill County, Nevada (CDC 2003a;
Rubin et al. 2007), and Sierra Vista, Arizona
(CCHD 2005), the CDC conducted detailed
laboratory analyses of biological samples. 
Recent Environmental Health
Initiatives That Impact Cluster
Response
Public demand for the investigation of the
relationship between environmental exposure
and disease has produced a number of signiﬁ-
cant technologic and programmatic advance-
ments, especially in data collection (cancer/
chronic disease registries), data quality (expo-
sure analysis and biomonitoring), and data
analysis (statistical methods in spatiotemporal
analysis and GIS). Progress in each of these
Cancer cluster activity at the CDC
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Figure 2. The 15 most commonly used environmental exposure terms found in articles pertaining to cancer
clusters published in U.S. newspapers from 1977 to 2001.
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of future cancer cluster studies. 
Data collection. Registries provide useful
information to estimate disease incidence and
prevalence, evaluate epidemics and disease
spread, monitor control and prevention meas-
ures, detect changes in health practices, recog-
nize newly emerging diseases, maintain a
historical archive of data, and facilitate epi-
demiologic research (Koo et al. 2005;
Macdonald et al. 1996; Teutsch and Thacker
1995; Thacker 1994). Implementation of sur-
veillance measures also serves to increase pub-
lic confidence in the commitment of the
government to protect public health (Hertz-
Picciotto 1996). 
Although national disease registries and
surveillance programs were initially designed
for infectious disease monitoring, the use of
registries for chronic disease surveillance has
gained increased popularity and funding over
the last several decades. (Berkelman and
Buehler 1990; Koo et al. 2005; Thacker et al.
1995). To detect elevated chronic disease levels
and to implement appropriate prevention pro-
grams, it is important to establish a baseline for
disease occurrence. This requires extensive reg-
istry-based databases about disease occurrence
under “usual” conditions (Rothenberg et al.
1990b). An increasing number of registries
have been established to track chronic adverse
health effects, with cancer registries emerging
as a gold standard in chronic disease surveil-
lance. (Koo et al. 2005; McGeehin et al. 2004;
Thacker and Stroup 1996).
The NCI initiated the Surveillance
Epidemiology and End Results (SEER) pro-
gram in 1973 to serve as an authoritative
source of information on cancer incidence and
survival in the United States (NCI 2006a).
SEER now provides cancer surveillance for
26% of the U.S. population (Wingo et al.
2003). In 1992 the U.S. Congress passed the
Cancer Registries Amendment Act (1992),
which called for the enhancement of existing
statewide cancer registries and authorized a
centralized cancer registry program to cover
those states not enrolled in SEER. As a result
of this congressional act, the CDC imple-
mented the National Program of Cancer
Registries (NPCR; http://www.cdc.gov/
cancer/npcr/index.htm; CDC 2006). NPCR
complements SEER programs by supporting
statewide cancer registries in 45 states, the
District of Columbia, and three U.S. territo-
ries. Together, SEER and NPCR cover
approximately 96% of the U.S. population
(Wingo et al. 2003). Registry certiﬁcation for
SEER and NPCR is provided by the North
American Association of Central Cancer
Registries (NAACCR 2006), which provides
guidance to all state registries to achieve data
content and compatibility levels acceptable for
pooling data and improving national estimates.
Since the publication of the 1990 guidelines
(CDC 1990), state and regional cancer reg-
istries have developed signiﬁcantly with respect
to registry numbers, capacity, and standardiza-
tion. As a result, cancer registry data will pro-
vide high-quality, timely information to
support response to concerned communities
and facilitate proactive early detection and
remediation, especially for cancers with short
latency periods (Elliott and Wartenberg 2004;
Koo et al. 2005; Raymond 1989; Thacker
1994).
An important initiative that will impact
the work of the CDC in cancer clusters is the
development of a national EPHT network. In
September 2000, the Pew Environmental
Health Commission recommended the cre-
ation of a coordinated public health system to
track diseases and environmental exposures
and to identify environmental health threats
(Environmental Health Tracking Project
Team 2000). In response, the U.S. Congress
funded the CDC in 2002 to begin the devel-
opment of an EPHT network that would link
information on environmental hazards,
human exposures to those hazards, and health
effects potentially related to those hazards
(McGeehin et al. 2004). The goal of this ini-
tiative is to integrate hazard monitoring,
exposure surveillance, and health effects sur-
veillance into a cohesive national EPHT net-
work. Information gained from this network
can be used to respond to and reduce the
burden of environment-related disease.
Partners in this effort include federal, state,
and local health and environmental agencies,
nongovernmental organizations, academic
institutions, health care organizations, and
community groups and members. As a result
of this program, geographic areas and popula-
tions likely to be affected by environmental
contamination will be identiﬁable, and com-
munities can be provided with valuable infor-
mation on their environment and potential
health implications. 
Data quality. Until recently, measure-
ments of human exposure to toxins were usu-
ally extrapolated from data collected by
environmental sampling, personal interview,
or exposure modeling (Lioy 1995; Sexton
et al. 1992). Efforts have recently shifted
toward the development of a wide array of
biological markers that can directly determine
the portion of a given chemical that enters the
body and at what level it can cause damage or
disease (Decaprio 1997; Sampson et al. 1994;
Sexton et al. 2004). Biomarkers of exposure,
effect, and susceptibility are currently meas-
ured in a variety of biological substances,
including blood (serum and peripheral blood
lymphocytes), urine, breast milk, feces, adi-
pose tissue, hair, nails, semen, exhaled breath,
and buccal, nasal, or bronchial epithelia (Barr
and Needham 2002; Sexton et al. 2004). 
Approximately 300 chemicals can cur-
rently be assayed by the NCEH Division of
Laboratory Sciences (CDC 2005a), including
polychlorinated biphenyls, dioxins, persistent
and nonpersistent organic pesticides and their
metabolites, polyaromatic hydrocarbon
metabolites, metals, volatile organic com-
pounds, and phytoestrogens. As part of the
National Health and Nutrition Examination
Survey (NHANES), the public health survey
conducted by the CDC National Center for
Health Statistics (Sexton et al. 2004), biologi-
cal samples collected from thousands of U.S.
residents are tested for numerous environ-
mental chemicals. The resulting data are used
to compile the CDC National Report on
Human Exposure to Environmental Chemicals.
This report is published every 2 years; the
2005 report includes 148 compounds (CDC
2005b). NHANES biomonitoring provides
baseline exposure data for a number of sub-
stances not previously monitored and has
been an important comparative tool in the
assessment of chemical exposures. 
Data analysis: available software and
calls for guidance. An appendix to the CDC
1990 disease cluster guidelines presented an
exhaustive summary of available methods to
test for spatial and/or temporal clustering
(CDC 1990). Although these methods
remain valid and actively used in cluster
investigations, many have limited application
in cancer cluster analysis because of the asso-
ciated complexities: long latency period, mul-
tiple exposures, genetic susceptibility,
migration, small area investigations with lim-
ited case numbers, and data quality and reso-
lution (Elliott and Wartenberg 2004; Jacquez
2004; Kulldorff and Hjalmars 1999;
Wakefield and Elliott 1999; Wartenberg
2001). Recognizing these limitations, scien-
tists have reﬁned existing methods and devel-
oped additional ones. The topic has been the
subject of lively discussion in the literature
(Cuzick and Edwards 1990; Jacquez et al.
1996b; Waller 2000; Wartenberg 1995;
Wartenberg and Greenberg 1993). Several
national and international workshops have
also addressed this issue: the 1992 Workshop
on “Statistics and Computing in Disease
Clustering” in Port Jefferson, New York; 
the 1994 Conference on “Statistics and
Computing in Disease Clustering” sponsored
by the NCI in Vancouver, British Columbia,
Canada; and the 1997 World Health
Organization “Disease Mapping and Risk
Assessment for Public Health” in Rome, Italy
(Jacquez et al. 1993, 1996a; Lawson et al.
2000; Wakefield et al. 2001). As a result of
the increased intensity in the field of cluster
statistics, more than 100 analytic methods are
currently available (NAACCR 2002).
A number of software programs and pack-
ages, from both private and public sectors, have
Kingsley et al.
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public health cluster response community
(Table 2). The choice of method is determined
by ease of use, user familiarity, and funds avail-
able for software, updates, and training (Jacquez
et al. 1996b; Wartenberg 2001; Wartenberg
and Greenberg 1993). To address the issue of
appropriate use of methodology in cancer
cluster analysis, expert panels have been orga-
nized and have provided concise and practical
guidance on choice of clustering methods and
software. For example, during the 2002 North
American Association of Central Cancer
Registries GIS workgroup meeting in
Princeton, New Jersey, organized by NAACCR,
the GIS subcommittee called for a systematic
review of currently available, open-access cluster
analysis software programs for cancer registries
(NAACCR 2004). The discussion resulted in
the publication of a detailed and systematic
comparison of four cluster software packages
(Crimestat, SaTScan, R-Geo, and GeoDa)
(Anselin 2004).
Methodologic guidance was also the impe-
tus for a 2002 NCI meeting on “Current
Practices in Spatial Data Analysis” in
Bethesda, Maryland, convened to focus specif-
ically on spatial data analysis. Proceedings
from this meeting were published in three
journal articles on cluster methodology that
summarize the state of the art, discuss ongoing
limitations, reinforce important caveats, and
envision future developments (Boscoe et al.
2004; Jacquez 2004; Pickle et al. 2005).
Increased attention to cancer cluster method-
ologies represents a signiﬁcant advancement in
its own right; however, published recommen-
dations for method selection vary, and the
need for extensive systematic comparisons of
different approaches remains (Jacquez 2004;
Wartenberg 1995; Wartenberg and Greenberg
1993). Although some studies have already
examined circumstance-appropriate applica-
tions for these methods (Hill et al. 2000; Song
and Kulldorff 2003), additional studies of this
nature should allow for clearer guidelines on
methods usage for the epidemiologist and
other disease cluster investigators.
Combining cluster methodologies with
GIS. Cluster analysis has been further bolstered
by the incorporation of GIS into the cancer
cluster approach. Basic GIS tools are now
being used routinely to depict and display
potential cancer clusters in visually compelling
ways, for example, the NCI Atlas of Cancer
Mortality for the United States (http://www3.
cancer.gov/atlasplus/; NCI 2006b). Recently,
more complicated applications for GIS have
included the active surveillance of cancer data
to detect cancer clustering, a venture requiring
coordinated implementation of GIS mapping
and statistics-based spatiotemporal cluster
analyses (Muravov et al. 1998; Rushton 2003;
Sheehan et al. 2000). 
However, unlike infectious diseases,
which are relatively limited in time and space,
chronic diseases such as cancer create analyti-
cal complexities not readily accommodated by
current conventional GIS techniques and
software packages (Jacquez 2004; Jarup
2004). Moreover, issues concerning the accu-
racy and quality of data, metadata standards,
inconsistent resolution of data points, aggre-
gated data usage, and issues of privacy and
confidentiality have yet to be fully resolved
(Elliott and Wartenberg 2004; Jacquez 2004;
Melnick and Fleming 1999; Nuckols et al.
2004; Waller 2000).
Extensive discussions about the use of GIS
in disease cluster analyses were held at the
1998 National Conference on GIS in Public
Health in San Diego, California (ATSDR
1998; Richards et al. 1999) and the 2002
North American Association of Central Cancer
Registries GIS Workgroup meeting in
Princeton, New Jersey (NAACCR 2002).
Critics of the current use of GIS in cluster
analysis note that this technology was origi-
nally developed for business purposes to gener-
ate static “snapshots” of locational information
(Thrall 1999). They suggest that this approach
would be more useful in investigating the etiol-
ogy of chronic diseases if it were reengineered
to evaluate geographic locations in a dynamic
time series (Jacquez 2004; Sabel et al. 2000).
Thus, while GIS technology gains momentum
in cluster investigations and is increasingly used
for cancer registries and by cluster responders,
new developments such as including more sys-
tematic approaches to cluster investigations,
improved accuracy in data acquisition, and
consideration of genetic susceptibility may be
necessary to achieve optimal results (Jacquez
2004; Pickle et al. 2005; Richards et al. 1999).
Conclusions 
Cancer cluster investigations occasionally have
led to the discovery of important pathways in
the etiology of specific cancers, such as with
angiosarcoma (Waxweiler et al. 1976), lung
cancer (U.S. Department of Health Education
and Welfare 1964), Kaposi sarcoma (CDC
1981, 1982), vaginal clear-cell carcinoma
(Herbst et al. 1971), bladder cancer (Villanueva
et al. 2003), and scrotal cancer (Pott 1775).
However, it is important to note that the
majority of these studies that yielded etiologic
information were studies of occupational, drug-
induced, or infectious pathogenic exposure
rather than studies of environmental exposure
(Caldwell 1990; Heath 2005). Nonetheless, in
some cases, geographic clusters with suspected
environmental etiology warrant follow-up
(Wartenberg 2001). Cluster response is appro-
priate public health practice, but resources must
be used efficiently and wisely. Responses to
cluster inquiries include addressing community
concerns, providing community education, and
informing the community about the progress of
investigations and/or exposure assessments. 
Recently, a paradigm shift in cluster
response has taken place: as analytic methods
improve, exposure assessment using biologic
sampling is now more commonly employed as
part of the public health response (Decaprio
1997). Consequently, signiﬁcant environmen-
tal exposure information may be obtained as
well as an increased potential for detection of
environment and disease relationships. Now
that baseline human exposure data are available
from the “Third National Report on Human
Exposure to Environmental Chemicals”
(CDC 2005b), results from biomonitoring
investigations may be much more meaningful. 
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Table 2. Software available for disease cluster analysis.
Software name/package Fee GIS functions Website Reference
CLUSTER 3.1 Yes None http://www.atsdr.cdc.gov/HS/cluster.html ATSDR 2005; Hall et al. 1996
ClusterSeer Yes Compatible http://www.terraseer.com/products/clusterseer.html Jacquez 1996; TerraSeer, Inc. 2006
CrimeStat 3.0 Yes None http://www.icpsr.umich.edu/NACJD/crimestat.html Levine 2004
DMAPa No Built in http://www.uiowa.edu/~gishlth/DMAP/ University of Iowa 1997
EpiAnalyst Yes Compatible http://www.phrl.org/REGS/Info%20EpiAnalyst.htm Research Epidemiology Geographic Software 2003
GeoDa 0.9.5-1a No Built in http://www.geoda.uiuc.edu/default.php Anselin 2003; Anselin et al. 2004
Point Pattern Analysis (PPA) No None http://www.nku.edu/~longa/cgi-bin/cgi-tcl-examples/ Alstadt et al. 1998
generic/ppa/ppa.cgi; http://www-rohan.sdsu.edu/~aldstadt/ 
tools.htm
R-Geo 2.0.0a No Compatible http://cran.r-project.org R Project 2004
S+SpatialStats Yes Compatible http://www.insightful.com Insightful Corporation 1999
SaTScana No None http://www.satscan.org Kulldorff and Nagarwalla 1995; SaTScan 2005
SpaceStat Yes Compatible http://www.terraseer.com/products/spacestat.html Anselin 2001
aFeatures of these software packages are compared in a review by Anselin (2004).Kingsley et al.
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The experience of federal, state, and local
public health agencies with cancer cluster con-
cerns and investigations has demonstrated the
influence that mass media may have on the
community concerning health, disease, and the
environment. Although the underlying science
of cancer cluster investigations is complex, the
importance of providing this information to
the public in a clear, balanced, and scientifi-
cally correct format cannot be overstated. 
Future Directions
The link to environmental exposures, whether
perceived or actual, is an important issue that
must be addressed. The many similarities
across states in their efforts to respond to can-
cer cluster inquiries create the opportunity for
state and federal agencies to better coordinate
their efforts. An important role for the CDC
is, and will continue to be, to facilitate com-
munication among states and others, to pro-
vide assistance when appropriate, to provide
increased access to relevant data, and to foster
the development of new systems, tools, and
approaches to cluster investigation. 
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